What's happening
This bill directs the New York Department of Health to study and recommend how to incentivize safe disposal of unused prescription drugs.
Why it matters
Addresses the opioid and prescription drug misuse crisis. by exploring structured ways to remove unused or unwanted drugs from homes, potentially reducing accidental poisonings, misuse, and diversion.
Considers holding pharmaceutical manufacturers financially responsible. for product end-of-life management, which could shift some costs from taxpayers to the industry and encourage safer drug distribution practices.
Explores direct consumer incentives (cash or coupon). for returning drugs, which may significantly increase participation rates in take-back programs compared to traditional, voluntary disposal efforts.
Mandates stakeholder engagement and public reporting. , ensuring that a variety of perspectives (health professionals, manufacturers, law enforcement, public health advocates) inform the recommendations and that the process remains transparent and accountable.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Study Drug Take-Back Program
Plain English, a few words. Used as the page title.
Sponsors
3 Co-sponsors
History
- Reported referred to ways and means
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Study Drug Disposal Program
In Senate Committee · Health · Sponsor Kemp Hannon
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8432
2017-2018 Regular Sessions
IN ASSEMBLY
June 16, 2017
Introduced by M. of A. GUNTHER -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to directing the department of health to conduct a prescription drug product stewardship disposal program study
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 3343-c to read as follows:
§ 3343-c. Prescription drug product stewardship disposal program study. The department shall study the feasibility of creating and mechanisms necessary to implement a product stewardship program whereby consumers would be incentivized and encouraged to return unused or unwanted controlled substances and other prescription drugs, and pharmaceutical manufacturers would be required to provide funding or coupons so that consumers returning such substances and drugs would receive either a cash or coupon incentive for such returns to an approved location for safe disposal. The department's study shall include stakeholder engagement and recommendations for implementing a prescription drug product stewardship disposal program. The department shall prepare and submit a report to the governor, the temporary president of the senate and the speaker of the assembly setting forth the information gathered and recommendations being put forth as a result of the study no later than May first, two thousand eighteen.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13134-02-7
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.